Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.
Launay et al compare the persistence of cross-neutralizing antibodies up to 3 months post-booster. The monovalent (MV) recombinant protein Beta-variant (MVB.1.351) vaccine induces higher and ...
The latest release of Trend Micro Antivirus+ Security adds two new and somewhat arcane features: AI App Protection and blocking of “potentially dangerous website notifications.” The latter is a simple ...